Results 191 to 200 of about 187,751 (309)

From Joint Clinical Assessment to National Decisions: EU HTA Implementation and Implications for Patient Access. [PDF]

J Mark Access Health Policy
D'Oca K, Adriano A, Darquennes E, Steck N.   +3 more
europepmc   +1 more source

Initiation of Gabapentin with Opioids and Risk of Respiratory Cardiovascular and Opioid‐Related Adverse Events Following Surgery for Breast Cancer

Clinical Pharmacology &Therapeutics, EarlyView.
Pain is a key determinant of quality‐of‐life following breast cancer surgery, the most common cancer operation in the United States. Gabapentinoids are frequently prescribed for pain management, yet their respiratory, cardiovascular, and opioid‐related adverse effects remain unclear.
Jyun‐Heng Lai, Anton L V Avanceña, Juan P Cata, Jamie C. Barner, Sharon H. Giordano, Chanhyun Park, Hui Zhao, Kirk E. Evoy, John K. Lin, Jennifer C. Spencer, Mariana Chavez‐MacGregor, Kelly K. Hunt, Kerollos Nashat Wanis   +12 more
wiley   +1 more source

History of drug pricing reform in the United States: from policy foundations to latest reforms. [PDF]

Health Aff Sch
Ramachandran S, Arabshomali A, Coster J.
europepmc   +1 more source

Researching Supply Reimbursement [PDF]

Ear, Nose & Throat Journal, 2005
openaire   +2 more sources

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

Clinical Pharmacology &Therapeutics, EarlyView.
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit, Maaike van Dartel, Laura Rodwell, Hanneke van der Woude, Cornelis Boersma, Peter G. M. Mol, Doranne Hilarius   +6 more
wiley   +1 more source

Bridging the gap: clinical practice, guidelines, reimbursement and real-world challenges in breast imaging - webinar highlights. [PDF]

Future Oncol
Reis J, Patel AK, Lopes M, van Nijnatten TJA, Lynch M, Ter Huurne F.   +5 more
europepmc   +1 more source

The Governance Gap: Democratizing Drug Development Through Decision Architecture

Clinical Pharmacology &Therapeutics, EarlyView.
Drug development is most exposed to governance failure where it can least afford it, in global health. The field has more predictive power than at any point in its history and roughly the same failure rate it had a decade ago. We argue that this paradox persists because the field has invested heavily in prediction science while neglecting decision ...
Craig R. Rayner, Nancy E. Martin, Danielle Smith, Eliza Kruger, Carl M.J. Kirkpatrick, Goonaseelan (Colin) Pillai, Katy Moore, Darrell Nix, Cristina Donini, Jakob P. Cramer, Edmundo Muniz, Natalia Muniz, Ernst Bos, Douglas McNair, Shyam Bhaskaran, Mark Sullivan, Dan Hartman   +16 more
wiley   +1 more source

Association between a regional reimbursement policy and treatment escalation in pulmonary arterial hypertension: a real-world cohort study with long-term Markov cost-effectiveness analysis. [PDF]

Front Pharmacol
Xie Y, Chen Y, Luo J, Chen J, Tan Y, Wang T, Chen W, Li J.   +7 more
europepmc   +1 more source

Unveiling spatial heterogeneity in urban underground space development patterns and mechanisms for differentiated planning: A points of interest‐based study of Shanghai

Deep Underground Science and Engineering, EarlyView.
This study investigated the spatial patterns and development mechanisms of urban underground space (UUS) in Shanghai using underground points of interest data. It revealed distinct development mechanisms between the main city and suburbs, highlighting the need for differentiated UUS planning and policies to optimize underground space resources ...
Chenxiao Ma, Fangle Peng, Yongkang Qiao, Yunhao Dong   +3 more
wiley   +1 more source

Global landscape of cranial prosthesis policies for medical hair loss: a narrative review. [PDF]

Front Public Health
Anaeme A, Lu J, Mann C.
europepmc   +1 more source